ABBOTT ELEMENTARY – “Picture Day” – When picture day catches the teachers at Abbott by surprise, chaos ensues. WEDNESDAY, JAN. 28 (8:30-9:02 p.m. EST) on ABC ...
Gov. Greg Abbott reacted to the latest events out of Minnesota and revealed that the White House "is working on a game plan" to recalibrate Immigration and Customs Enforcement. "They, being the White ...
Abbott Laboratories (NYSE:ABT) Q1 2025 Earnings Call Transcript April 16, 2025 Abbott Laboratories beats earnings expectations. Reported EPS is $1.09, expectations were $1.07. Operator: Good morning, ...
Abbott Laboratories reported Q4 2025 sales of $11.46 billion, an increase of 4.4% from the previous year but falling short of analyst projections by approximately 3%. The adjusted EPS was $1.50, ...
Abbott Laboratories stock slid Thursday after the medical-products maker reported disappointing results, hit by a slump in the division that makes baby formula and nutrition shakes. Abbott shares ...
Abbott is teaming up with AtaCor Medical to develop a next-generation implantable cardioverter defibrillator (ICD) designed to treat dangerous cardiac arrhythmias without routing wires through the ...
School is back in session for the pupils and teachers of Abbott Elementary after a much-needed winter break. After learning some not-so good news about the state of the school, the Abbott crew is ...
Efforts to legalize casino gambling in Texas have failed in recent legislative sessions, but the industry isn't giving up. In an interview with CBS News Texas in Fort Worth, Gov. Greg Abbott said he's ...
The family of Texas A&M sophomore Brianna Aguilera is now urging Gov. Greg Abbott and the Texas Rangers to take over the probe into the 19-year-old’s death, escalating their battle with Austin police.
Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...
Abbott Laboratories (NYSE: ABT) agreed on Thursday to acquire cancer screening company Exact Sciences Corp (NASDAQ: EXAS) for $105 per common share, representing a total equity value of approximately ...
North suburban-based Abbott Laboratories announced a $21 billion deal Thursday morning to acquire Exact Sciences, the maker of Cologuard — its largest acquisition in a decade. The deal will allow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results